Compare BTE & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTE | TMDX |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2004 | 2019 |
| Metric | BTE | TMDX |
|---|---|---|
| Price | $4.07 | $71.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $148.22 |
| AVG Volume (30 Days) | ★ 20.0M | 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.28% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | N/A | $24.25 |
| Revenue Next Year | $7.93 | $18.75 |
| P/E Ratio | ★ $18.43 | $360.95 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $1.81 | $60.11 |
| 52 Week High | $5.36 | $156.00 |
| Indicator | BTE | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 47.39 |
| Support Level | $3.91 | $64.87 |
| Resistance Level | $4.56 | $80.72 |
| Average True Range (ATR) | 0.12 | 3.62 |
| MACD | 0.03 | 0.28 |
| Stochastic Oscillator | 59.42 | 41.84 |
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.